HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.060
Day range
$0.066 - $0.070
Year range
$0.034 - $0.14
Market cap
12.06M USD
Avg Volume
38.08K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 813.20K | 7.07% |
Net income | -730.96K | -9.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.38M | -33.12% |
Total assets | 6.45M | -32.85% |
Total liabilities | 3.04M | -3.54% |
Total equity | 3.41M | — |
Shares outstanding | 172.32M | — |
Price to book | 3.00 | — |
Return on assets | -29.84% | — |
Return on capital | -53.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -730.96K | -9.96% |
Cash from operations | -720.44K | -28.03% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -720.44K | -28.03% |
Free cash flow | -497.73K | -33.02% |
About
Founded
1992
Headquarters
Website
Employees
6
